STAT3 and Lymphadenopathy: Autosomal dominant germline gain-of-function (GOF) variants in STAT3 result in a PIRD characterized by immune dysregulation and a broad spectrum of clinical features, including cytopenias, lymphadenopathy, interstitial lung disease, enteropathy, and polyendocrinopathy (14, 15).